Ultragenyx Pharma (RARE) PT Raised to $72 at Citi After Analyst Day
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $72.00 (from $62.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
